This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Early Diagnosis and Management of Alzheimer’s Disease

Barbara A. Duncan, M.S.N., A.P.R.N.; and Alan P. Siegal, M.D.

Published: March 1, 1998

Article Abstract

It is only recently that Alzheimer’s disease has become recognized as a major public health concern.Not only those diagnosed with Alzheimer’s disease are impacted by the disease; the emotionaltoll exacted on caregivers is enormous, and the financial costs incurred by the United States are staggering.Early diagnosis of Alzheimer’s disease can prevent costly and inappropriate treatment and permitsearlier treatment of symptoms. There have been several recent pharmacologic advances in thetreatment of Alzheimer’s disease, including the development of acetylcholinesterase inhibitors. Forany intervention to prove successful, however, early and accurate diagnosis and effective diseasemanagement are crucial.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 59

Quick Links: Dementia , Neurologic and Neurocognitive

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...